BCBenoit Cossette

Benoit Cossette

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Benoit Cossette has a total of 211 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Response to the correspondence regarding “Association between anticholinergic and sedative medications and physical functioning: data from the Canadian Longitudinal Study on Aging (CLSA)”

    by Benoit Cossette, Keren Pelen, Karina Lebel, Marie-Laure Baroud, Caroline Sirois, Lauren E. Griffith, Frank Moriarty, Alexandra Mayhew, Patrick Boissy, Jean-Philippe Turcotte, et al.

  • Open Access

    Six-year trajectories of social participation and connection among aging women and men: Comparison and best predictors from the Canadian Longitudinal Study on Aging (CLSA)

    by Mélanie Levasseur, Daniel Naud, Marie-France Dubois, Harry Taylor, Mélissa Généreux, Benoît Cossette, Lauren E. Griffith, Stéphanie Lanthier-Labonté, Andrew Wister

  • Association between anticholinergic and sedative medications and physical functioning: data from the Canadian longitudinal study on aging (CLSA)

    by Keren Pelen, Patrick Boissy, Karina Lebel, Alexandra Mayhew, Marla K Beauchamp, Lauren E Griffith, Megan E O’COnnell, Sarah N Hilmer, Marie-Laure Baroud, Caroline Sirois, et al.

    The cumulative use of anticholinergic and sedative medications has been associated with lower physical function in older adults. This study aimed to identify which physical function attributes are most impacted in subgroups aged 45-64 and 65-85 years. Baseline data from 30,097 community-living Canadians in the Canadian Longitudinal Study on Aging were analysed using a cross-sectional design. Anticholinergic and sedative medications use was quantified using the Drug Burden Index (DBI). Physical functioning was measured via the timed 4-meter walk, Timed Up and Go (TUG), single leg balance, chair rise and grip strength. Physical functioning profiles were generated using latent profile analysis of the five tests. Associations between DBI scores and physical functioning were assessed through linear regression and multinomial logistic regression. The mean age of participants was 63.0, 50.9% were female, 18.3% had a DBI score 0 < DBI < 1 and 8.7% a DBI score ≥ 1. Adjusted regression models showed the greatest reduction in standardized scores for the TUG test among participants with DBI ≥ 1 (β: -6.05; -6.77 to - 5.33) relative to DBI = 0. Latent profile analysis indicated that the two profiles with the poorest physical functioning were associated with higher odds of exposure to 0 < DBI < 1 and DBI ≥ 1, whereas the profile reflecting the best functioning was associated with reduced odds of exposure to DBI ≥ 1. Associations of similar magnitude were observed across age strata (45-64 and 65-85 years). Cumulative anticholinergic and sedative medication burden was inversely associated with physical functioning. These findings were consistent across middle-aged and older adults.

  • Open Access

    Six-year trajectories of social participation and connection among aging women and men: Comparison and best predictors from the Canadian Longitudinal Study on Aging (CLSA)

    by Mélanie Levasseur, Marie-France Dubois, Harry Taylor, Mélissa Généreux, Benoît Cossette, Lauren E. Griffith, Stéphanie Lanthier-Labonté, Andrew Wister

    Although social participation and connection are essential for healthy aging, many older adults face isolation. Since most studies are cross-sectional, little is known about the trajectories of social participation and connection. This study aimed to compare social participation and connection trajectories among aging women and men, and examine their predictors. Secondary analyses of 6-year longitudinal data from the Canadian Longitudinal Study on Aging were conducted at baseline (2011-2015), and follow-ups 1 (2015-2018) and 2 (2018-2021; n=44,967; 62.8±10.3). Social participation and connection were modeled using group-based multi-trajectory modelling. Multilevel multinomial logistic regressions identified baseline individual and environmental predictors. Four trajectories were identified (most to least prevalent): Moderate-high, Moderate, Low, and High. Participation decreased but women globally maintained higher participation than men, and connection remained similar over time and across sexes. Being older, lower mobility, insufficient income, and poor self-perceived physical and mental health were associated with less favorable trajectories for both sexes. For both sexes, immigration status increased the odds of less favorable trajectories (except the Low one among men), conversely visible minority status increased the likelihood of following the High trajectory. 16-37% of the latent variance of trajectories was attributable to community-level. Social deprivation increased the odds of less favorable trajectories, whereas lower walkability was associated with higher odds of being in the Moderate-high and High trajectories. Social participation and connection trajectories are shaped by place and space. These findings suggest that sex-specific, age-friendly urban planning and economic support are essential for maintaining social participation and connection in later life.

  • Open Access

    Association entre l’usage des médicaments anticholinergiques et sédatifs et le sommeil des participants de l’Étude longitudinale canadienne sur le vieillissement

    by Willy-Brad Hagenimana, Benoit Cossette, Yohann Moanahere Chiu

    Des médicaments anticholinergiques et sédatifs sont fréquemment prescrits afin d’améliorer le sommeil des personnes aînées. Les anticholinergiques agissent sur l’acétylcholine, un neurotransmetteur clé dans la régulation des cycles du sommeil. Parmi les sédatifs, les benzodiazépines amplifient l’action inhibitrice du gamma-aminobutyric acid (GABA) en en se liant au récepteur GABA-A. Certains médicaments sont spécifiquement indiqués pour le sommeil (benzodiazépines, « z-drugs ») et d’autres sont utilisés hors indication (antidépresseurs, antipsychotiques). Malgré leur utilité, plusieurs études ont indiqué que l’effet anticholinergique/sédatif cumulatif peut affecter négativement le sommeil. Cependant, à notre connaissance, aucune étude n’a exploré les associations entre cette charge et le sommeil. Cette étude évalue directement ces associations.

  • Open Access

    Association entre la charge médicamenteuse anticholinergique et sédative et les paramètres dynamiques de marche chez les aînés : une étude transversale

    by Marie-Laure Baroud, Karina Lebel, Benoit Cossette

    Chez les personnes âgées, les médicaments ayant des propriétés anticholinergique ou sédative augmentent le risque de déclin fonctionnel et de chutes. La qualité de la marche pourrait constituer un marqueur sensible des effets indésirables médicamenteux. Cette étude vise à examiner l’association entre la polypharmacie et le Drug Burden Index (DBI), une mesure de la charge médicamenteuse anticholinergique et sédative, et les paramètres dynamiques de marche chez les aînés.

  • Open Access

    Du GAP au pharmacien communautaire : profil et trajectoire des personnes aînées orphelines en Montérégie

    by Dylan Bonnan, Catherine Lamoureux-Lamarche, Mylaine Breton, Benoit Cossette

    Au Québec, plus de 30 % de la population (orpheline) n’est pas inscrite auprès d’un médecin de famille ou d’une IPS pour répondre à ses besoins de soins. Sachant que 72 % des personnes aînées utilisent cinq médicaments ou plus quotidiennement, celles n’étant pas rattachées à un médecin de famille n’ont pas accès aux services nécessaires pour le suivi adéquat de leur médication complexe. Pour permettre à ces patients d’accéder aux soins dont ils ont besoin, les guichets d’accès à la première ligne (GAP) ont été instaurés dans chacune des régions du Québec en 2022. Ils visent à orienter les patients vers le professionnel approprié en fonction de leurs besoins. Les pharmaciens communautaires, qui disposent d’un champ de pratique avancée (ajustement de la médication, prescription pour des conditions mineures), font partie des professionnels auxquels les patients peuvent être référés par le GAP pour répondre aux besoins de soins et de services en lien avec la médication des aînés orphelins. Cependant, le profil et l’expérience des personnes aînées référées à un pharmacien communautaire demeurent peu documentés.

  • Open Access

    Structured Clinical Tools for Periodic Health Assessment of Older Adults in Primary Care: A Scoping Review

    by Marie‐Pier Villemure, Benoît Cossette, Pierre‐Vincent Breault‐Ruel, Alexandre Camirand, Catherine Hudon

    Background and Aims: Delivering preventive care to older adults presents challenges due to the lack of consensus on screening items, particularly regarding geriatric syndromes. Furthermore, chronological age often differs from biological age, which requires primary care clinicians (PCCs) to assess each patient's aging profile and tailor preventive interventions accordingly. Periodic Health Assessments (PHAs) offer an opportunity to administer preventive care. While several authors have developed Structured Clinical Tools (SCTs) to assist clinicians during PHAs, no SCT is widely used across clinicians. The study aims to identify existing SCTs for the PHA of older adults and evaluate their content, formats, and practical usability. Methods: We conducted a scoping review following the 6‐step methodology recommended by Arksey and O'Malley (2005) and Levac (2010). We searched in PubMed, CINAHL, and Ageline, as well as in the grey literature, using keywords related to four main concepts: older adults, primary care, periodic health assessment, and SCT. We retrieved SCTs published in French and English between 2000 and 2024. Data were screened and charted by two independent reviewers. For step six (consultation), we gathered opinions of 10 PCCs on the practical usability of different SCTs. Results: Among the 8029 identified publications, we retrieved 16 distinct SCTs. Design objectives and conception processes of these SCTs varied. They were presented in various formats, including questionnaires, tables, schemas, checklists, acronyms, and mnemonics. While all SCTs addressed geriatric syndromes, only two adapted their recommendations to patients' aging profiles. Consulted PCCs emphasized that an ideal SCT should be integrated into an electronic health record, accommodate various aging profiles, and rely on evidence‐based medicine. Conclusions: A reliable and user‐friendly SCT for the PHA of older adults would facilitate the delivery of preventive care. However, no published SCTs to date meet the expectations of PCCs. Further research is necessary to develop one.


  • Prevalence and factors associated with anticholinergic medication use in community-dwelling older adults: a systematic review

    by Keren Pelen, Willy-Brad Hagenimana, Marie-Laure Baroud, Yohann Moanahere Chiu, Hassiba Chebbihi, Karina Lebel, Patrick Boissy, Benoit Cossette

    Introduction Medications with anticholinergic effects are widely used despite the mounting evidence of physical and cognitive impairment associated with their use among older adults. Aim A systematic review was conducted to describe the prevalence of anticholinergic medication use in community-dwelling older adults, document the factors associated with their use and describe the most frequently used medication classes. Method MEDLINE, Embase and CINAHL were searched from inception to May 2024. All study designs except case reports and case studies were eligible if they included community-dwelling older adults aged 65 and older and assessed the factors associated with anticholinergic medication use. An open-source artificial intelligence screening tool was used to optimise title and abstract screening. The subsequent review of the full texts of potentially eligible studies and data extraction were conducted in the Covidence systematic review tool using standardised data collection forms. Study quality was assessed with the Newcastle–Ottawa scale. The study selection, data extraction and quality assessment were conducted independently by two reviewers. Results From 4139 records of interest, the seven selected studies included five cross-sectional and two retrospective studies, published between 2014 and 2021. The risk of bias was assessed to be low in five studies and high in two studies. Greater anticholinergic burden was associated with female sex, lower socioeconomic status, higher co-morbidity score, higher frailty probability, specific diseases, polypharmacy and greater use of healthcare, while increasing age was associated with both increased and decreased anticholinergic burden. Anticholinergic exposure, varied from a low of 6.2% of medical visits in the United States between 2006 and 2015, assessed with the 2015 Beers Criteria and the Anticholinergic Risk Scale, to a high of 72.8% of medication claims (dispensed medications) in South Korea, over the year 2012, assessed with the 2015 Beers Criteria and the Anticholinergic Burden Scale. The use of six different anticholinergic scales and different evaluation periods did not allow a meaningful comparison of the prevalence of anticholinergic exposure across studies. Antidepressants, antihistamines and antimuscarinics were the most common medication classes in the two studies using this classification. Conclusion This systematic review documented key socioeconomic and health status factors to be targeted by interventions aimed at limiting the use of anticholinergic medications in community-dwelling older adults.


  • Open Access

    Cost trends of potentially inappropriate medications among older adults between 2012 and 2021 in Quebec, Canada: a population-based repeated cross-sectional study

    by Magalie Gagnon, Jason Robert Guertin, Caroline Sirois, Marc Simard, Benoît Cossette, Marie-Eve Gagnon

    Background: Potentially inappropriate medications (PIMs) are frequent in older adults, contributing to hospitalizations, adverse events, and healthcare burden. We aimed to estimate direct PIM cost trends from 2012 to 2021 among older women and men in Quebec, Canada. Methods: Using medico-administrative data, we assessed direct costs paid by the public insurer (medication cost and professional fee, excluding out-of-pocket payments by individuals) of PIMs claimed by adults ≥65 years covered by the public drug plan. Costs for 16 PIM classes, identified using 2015 and 2019 Beers criteria, were calculated and stratified by sex and age group (65-74, 75-84, ≥85) for each fiscal year. We assessed the proportion of PIMs among all medication expenditures. We computed average costs/enrollee and usage prevalence for the costliest PIM classes. Trends were estimated using univariate linear regression with 95% confidence intervals. Results: We found a non-statistically significant decrease in total PIM claim costs, from $206 million in 2012 to $186 million in 2021 (trend: -2.9[-17.4; 11.6]), representing 5.4% of medication expenditures for adults ≥65 in 2021. The reduction in total costs was more accentuated in women, whose annual costs were higher than those of men in all age groups. Average cost/enrollee decreased from $179 to $119 (trend: -7[-19; 5]), with a drop from $216 to $142 for women and $132 to $92 for men. Costs/enrollee were higher in 75-84 and ≥85 age groups. Costliest PIM classes included proton-pump inhibitors, benzodiazepines, antipsychotics, antidepressants, estrogens (women), and hypoglycemic agents (men). Cost trends did not always follow prevalence trends for these PIM classes. Conclusion: PIM costs among older adults slightly decreased from 2012 to 2021. Appropriate prescribing and deprescribing appear crucial for reducing these costs. Further research should focus on estimating the societal impact and the cost-effectiveness analysis of deprescribing initiatives and other regulatory measures.